ArticleCMAJ open
Use of patient-reported outcomes in regional cancer centres over time: a retrospective study.
Article in CMAJ open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Interventions for Concerning Patient-Reported Outcomes in Routine Cancer Care: A Systematic Review.Annals of surgical oncology · 2024Pooled it
- Development of Machine Learning Systems to Predict Cancer-Related Symptoms With Validation Across a Health Care System.JCO clinical cancer informatics · 2025Article
- Healthcare utilization among survivors of childhood and adolescent cancer: a population-based study.Journal of cancer survivorship : research and practice · 2025Article
- The Edmonton Symptom Assessment System is a valid, reliable, and responsive tool to assess symptom burden in decompensated cirrhosis.Hepatology communications · 2024Article
- Impact of chronic obstructive pulmonary disease on lung cancer symptom burden: a population-based study in Ontario, Canada.Translational lung cancer research · 2023Article
- Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App.JCO oncology practice · 2023Article
- Experience With the Routine Use of Electronic Patient-Reported Outcome Measures for Patients With Lung Cancer.JCO clinical cancer informatics · 2023Article
- Diagnostic timelines and self-reported symptoms of patients with lung and gastrointestinal cancers undergoing radiation therapy. Retrospective case control study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- The impact of symptom screening on survival among patients with cancer across varying levels of pre-diagnosis psychiatric care.Cancer medicine · 2022Article
- The effectiveness of a provincial symptom assessment program in reaching adolescents and young adults with cancer: A population-based cohort study.Cancer medicine · 2021Article
- Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.The oncologist · 2021Article
- Selecting, implementing and evaluating patient-reported outcome measures for routine clinical use in cancer: the Cancer Care Ontario approach.Journal of patient-reported outcomes · 2020Article
- The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis.Cancer medicine · 2020Observational
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSince 2007, Cancer Care Ontario has been collecting data using the Edmonton Symptom Assessment System as a patient-reported outcome measure for use in routine care. The purpose of this project was to evaluate the factors associated with Edmonton Symptom Assessment System uptake among cancer patients seen at regional cancer centres and to examine if these associations have changed over time.
methodsThis was a retrospective cohort study among cancer patients eligible to complete Edmonton Symptom Assessment System assessments who were seen at regional cancer centres in Ontario between 2007 and 2015. We used linked administrative sources of health care data. Our primary outcome for each patient was defined as the rate of ESAS assessments, which was analyzed overall and on an annual basis.
resultsWe identified 525 409 unique patients with at least 1 visit to a cancer centre during the study period. The percentage of patients with at least 1 Edmonton Symptom Assessment System assessment increased from 5% in 2007 to 67% in 2015. Analysis demonstrated that variation by region and by cancer type decreased over time: relative rates for region ranged from 0.31 to 13.3 in 2007 whereas they ranged from 0.7 to 1.56 in 2015, and relative rates for cancer type ranged from 0.03 to 1.0 in 2007 whereas they ranged from 0.55 to 1.0 in 2015. In 2015 women and people living in poorer neighbourhoods had a lower Edmonton Symptom Assessment System uptake (relative rate 0.93 and 0.91, respectively).
interpretationOntario has implemented a patient-reported outcome program across the province; over time, uptake has improved and variation by cancer type and region has decreased. Variation persists for other patient characteristics, which suggests that there are opportunities to improve equity in the program.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.